AcureX Therapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
930 Brittan Ave, San Carlos, California,...Website
www.acurex.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
1
1
About AcureX Therapeutics
AcureX Therapeutics is a biotechnology company developing small molecule drug candidates with the mission of halting neurodegenerative diseases starting with Parkinsons Disease. The company is based in San Carlos, California.Explore more
AcureX Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AcureX Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if AcureX Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if AcureX Therapeutics is spiking on competitors!
Product Launch: Get notified when AcureX Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at AcureX Therapeutics
Earning: See what the market has to say on AcureX Therapeutics recently announced quarterly report
AcureX Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if AcureX Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once AcureX Therapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to AcureX Therapeutics
Compare insights from companies similar to AcureX Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AcureX Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
AcureX Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AcureX Therapeutics.
AcureX Therapeutics Tech Stack
A closer look at the technologies used by AcureX Therapeutics
Most Recent Scoops
Event
Person-Based
Events, Podcast
Event
Events
Executive Move
Board of Directors
Funding
Funding
AcureX Therapeutics News & Media
Acurex Biosciences Appoints Esteemed Biopharmaceutical Leader Dr. Robert Booth to its ...
Acurex Biosciences Corporation, a biopharmaceutical company with a mission to stop neurodegeneration before it begins, announces the appointment of reAcurex Biosciences Appoints Esteemed Biopharmaceutical Leader Dr. Robert Booth to its Board of Directors
SAN CARLOS, Calif.--(BUSINESS WIRE)--Acurex Biosciences Corporation, a biopharmaceutical company with a mission to stop neurodegeneration before it begins, announces the appointment of renowned biopharmaceutical industry leader Dr. Robert Booth to its Board of Directors. Dr. Booth, distinguished for his invaluable contributions to the biopharmaceutical industry, brings over 30 years of experience in drug discovery, development, and executive leadership. Dr. Booth earned his Ph.D. in biochemistrAcurex Biosciences to Present Early Clinical Results Supporting its Novel Parkinson’s Disease Biomarkers at a Michael J. Fox Foundation Biomarkers Workshop
SAN CARLOS, Calif.--(BUSINESS WIRE)--Acurex Biosciences Corporation, a privately-held biopharmaceutical company with a mission to stop neurodegeneration before it starts, has been selected to present early results on its IRB-approved clinical trial for Parkinson’s disease (PD) patients. This longitudinal study evaluates Acurex’s first-in-class non-invasive biomarkers that detect the underlying biology of neurodegenerative disease pathology. Parkinson’s disease is the second most common neurodegAcureX Therapeutics Receives Grant Funding from The Michael J. Fox Foundation For Parkinson’s Research
SAN CARLOS, Calif.--(BUSINESS WIRE)--AcureX Therapeutics Corporation, a privately-held preclinical-stage biopharmaceutical company focused on developing potential disease altering therapeutics for neurodegenerative diseases, today announced that it was selected to receive a grant from The Michael J. Fox Foundation to accelerate the development of AcureX’s biomarker for use in Parkinson’s disease drug development and clinical trials. Parkinson’s disease (PD) is a debilitating neurodegenerative d
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AcureX Therapeutics
Sign Up For FreeTo access detailed company insights
AcureX Therapeutics is a biotechnology company developing small molecule drug candidates with the mission of halting neurodegenerative diseases starting with Parkinsons Disease. The company is based in San Carlos, California.... Read More
